scPharmaceuticals reported a net loss of $18.8 million for the fourth quarter of 2024, compared to $13.8 million for the fourth quarter of 2023. For the full-year 2024, scPharmaceuticals reported a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback